Real-time enrollment status for this metastatic solid tumor clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 8:15 PM UTC
| NCT Number | NCT06465069 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 420 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT06465069 is currently recruiting participants. This phase1 study for metastatic solid tumor is actively seeking new participants at 23 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06465069 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06465069 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.